Asstra Pharrma Private Limited - Due diligence report

A 360° intelligence report on Asstra Pharrma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2017-05-31 Qutubullapur, Telangana Active Unlisted Active Compliant
Share
View plans
AP Asstra Pharrma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Asstra Pharrma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Asstra Pharrma Private Limited is assessed as Moderate with a Trust Score of 72/100. Asstra Pharrma Private Limited is an active private limited indian non-government company incorporated in 2017, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 03 Jul 2026 from the latest processed filings. Asstra Pharrma Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2021 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MIDDE AZEEM ABDUL 01234567 Director 01/04/2018 6 yrs Approved
SURAJ SALEEM SHAIK MIDDE 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 65
Growth signals & trust indicators
Steady revenue growth: +2.1x over 2 year(s).
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view63/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
05 Aug 2023
Director ceased
SANDEEP POREDDY
Director ceased
PRADEEP REDDY POREDDY
02 Aug 2023
Director appointed
MIDDE AZEEM ABDUL (Director)
Director appointed
SURAJ SALEEM SHAIK MIDDE (Director)
30 Nov 2021
Last AGM held
Annual general meeting
26 Apr 2021
Director ceased
SUJATHA POREDDY
31 Mar 2021
Latest balance sheet
Filed with ROC
31 May 2017
Incorporated
Registered with Roc Hyderabad
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 2 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Abt Foundation Limited U70101TZ2009PLC015300 Coimbatore, Tamil Nadu, India
Gurukul Impex Private Limited U36912GJ2013PTC077873 Surat, Gujarat, India
Dhanshree Dealer Private Limited U51101WB2010PTC144033 Kolkata, West Bengal, India
Aman Paddy Processors Private Limited U15209TG1999PTC032511 Andhra Pradesh, Telangana, India
Advantage Overseas Private Limited U05121MH2004PTC199195 Mumbai, Maharashtra, India
Tufcare Pharma Private Limited U24232OR2015PTC018758 Bhubaneswar, Orissa, India
Gold Star Poly Weave Limited U29300MH1995PLC092969 Mumbai, Maharashtra, India
Sas Holding Private Limited U17120DL2014PTC271490 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Asstra Pharrma Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Asstra Pharrma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Asstra Pharrma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Asstra Pharrma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Asstra Pharrma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Asstra Pharrma Private Limited an active company?

Asstra Pharrma Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Asstra Pharrma Private Limited financially healthy?

Asstra Pharrma Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Asstra Pharrma Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Asstra Pharrma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Asstra Pharrma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Asstra Pharrma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Asstra Pharrma Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.